| abstract |
The present invention relates to benzoylguanidine of formula (1), which is an active antiarrhythmic agent and cardioprotective component and is well suited for the prevention and treatment of infarction and for treatment during angina, in which case they also develop ischemic induced damage Prophylactically inhibit or greatly reduce pathophysiological processes, especially in the development of ischemic-induced deep veins.n n n n n n n n In the above formula, R1 to R6 are described in the claims. |